![Shaheen Wirk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shaheen Wirk
Directeur Général chez
Palkon Capital Management LLC
Fortune : 337 969 $ au 31/07/2026
Profil
Shaheen Wirk is the founder of Palkon Capital Management LLC, serving as Portfolio Manager since 2012.
Current jobs include Director-Medical Alumni Council at Duke University School of Medicine and Independent Director at Movano, Inc. Former jobs include Independent Director at Tvardi Therapeutics, Inc. in 2025 and Director at Tvardi Therapeutics, Inc. (Old) from 2021 to 2025.
Education includes an MBA from The Fuqua School of Business in 2002 and undergraduate, MBA, and doctorate degrees from Duke University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,08% | 13/03/2026 | 21 674 ( 0,08% ) | 234 513 $ | 31/07/2026 |
0,53% | 15/04/2025 | 49 265 ( 0,53% ) | 103 457 $ | 31/07/2026 |
Postes actifs de Shaheen Wirk
| Sociétés | Poste | Début |
|---|---|---|
Palkon Capital Management LLC
 Palkon Capital Management LLC Investment ManagersFinance Palkon invests in innovative private and public life sciences companies. By investing in development stage healthcare companies, they can simultaneously catalyze innovation that addresses unmet medical needs and capture key value inflections. | Directeur Général | 01/09/2012 |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Shaheen Wirk
| Sociétés | Poste | Fin |
|---|---|---|
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Directeur/Membre du Conseil | 15/04/2025 |
Movano, Inc.
 Movano, Inc. Packaged SoftwareTechnology Services Develops software based non-invasive continuous glucose monitoring devices | Directeur/Membre du Conseil | - |
Formation de Shaheen Wirk
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palkon Capital Management LLC
Palkon Capital Management LLC Investment ManagersFinance Palkon invests in innovative private and public life sciences companies. By investing in development stage healthcare companies, they can simultaneously catalyze innovation that addresses unmet medical needs and capture key value inflections. | Finance |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
Movano, Inc.
Movano, Inc. Packaged SoftwareTechnology Services Develops software based non-invasive continuous glucose monitoring devices | Technology Services |
